Introduction: The potentials of Africa for growth and economic transformation through science remains challenging because of existing gaps in knowledge and infrastructure. The Africa Pharmacological Science Gateway project and the Medicines Utilization Research in Africa Group seeks to meet the research needs of African pharmacologists. This study aimed at identifying priority needs that might be met by access to information and tools through e-infrastructure. Methods: A web-based cross-sectional study among 472 members of pharmacological societies in Africa to obtain information on their research interests and skills, available resources, needs and knowledge gaps. Descriptive analyses were done. Results: A total of 118 responses from 13 co...
Global research and development (R&D) pipelines for diseases that disproportionately affect African ...
Introduction: Provision of access to drug information by prescribers and other health care professio...
Growing burden of infectious and NCDs across Africa, e.g. 70% of world’s HIV patients live in sub-Sa...
Introduction: The potentials of Africa for growth and economic transformation through science remain...
INTRODUCTION:The potentials of Africa for growth and economic transformation through science remains...
Over the years, under the North-South (N-S) Scientific and Technology transfer drive, many African s...
Growing burden of communicable and non-communicable diseases in sub-Saharan Africa has necessitated ...
This two day meeting brought together drug utilisation researchers from across Africa. The purpose w...
The improper use of medicines is a major cause of poor therapeutic effect as well as adverse drug re...
Africa is one of the world’s fastest-growing economic regions, with a rise in its pharmaceutical ind...
In Nigeria, medical students are trained in more didactic environments than their counterparts in re...
The second Medicines Utilization Research in Africa (MURIA) group workshop and symposium again broug...
Background: In recent years there have been calls to strengthen health sciences research capacity in...
South Africa recently became the first African country where clinical pharmacology has been approved...
Background: Achieving sustainable universal health coverage depends partly on fair priority-setting ...
Global research and development (R&D) pipelines for diseases that disproportionately affect African ...
Introduction: Provision of access to drug information by prescribers and other health care professio...
Growing burden of infectious and NCDs across Africa, e.g. 70% of world’s HIV patients live in sub-Sa...
Introduction: The potentials of Africa for growth and economic transformation through science remain...
INTRODUCTION:The potentials of Africa for growth and economic transformation through science remains...
Over the years, under the North-South (N-S) Scientific and Technology transfer drive, many African s...
Growing burden of communicable and non-communicable diseases in sub-Saharan Africa has necessitated ...
This two day meeting brought together drug utilisation researchers from across Africa. The purpose w...
The improper use of medicines is a major cause of poor therapeutic effect as well as adverse drug re...
Africa is one of the world’s fastest-growing economic regions, with a rise in its pharmaceutical ind...
In Nigeria, medical students are trained in more didactic environments than their counterparts in re...
The second Medicines Utilization Research in Africa (MURIA) group workshop and symposium again broug...
Background: In recent years there have been calls to strengthen health sciences research capacity in...
South Africa recently became the first African country where clinical pharmacology has been approved...
Background: Achieving sustainable universal health coverage depends partly on fair priority-setting ...
Global research and development (R&D) pipelines for diseases that disproportionately affect African ...
Introduction: Provision of access to drug information by prescribers and other health care professio...
Growing burden of infectious and NCDs across Africa, e.g. 70% of world’s HIV patients live in sub-Sa...